Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival
- 1 July 1997
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 117 (1) , 93-98
- https://doi.org/10.1016/s0304-3835(97)00206-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Genistein, a Tyrosine Kinase Inhibitor, Reduces EGF-Induced EGF Receptor Internalization and Degradation in Human Hepatoma HepG2 CellsBiochemical and Biophysical Research Communications, 1996
- Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude miceBritish Journal of Cancer, 1995
- Cantharidin Effects on Protein Phosphatases and the Phosphorylation State of Phosphoproteins in MiceToxicology and Applied Pharmacology, 1995
- Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2AFEBS Letters, 1993
- Improved Survival for Hepatocellular Cancer With Combination Surgery and Multimodality TreatmentAnnals of Surgery, 1993
- Cantharidin-binding protein: identification as protein phosphatase 2A.Proceedings of the National Academy of Sciences, 1992
- Systemic chemotherapy for hepatocellular carcinomaPublished by Springer Nature ,1992
- Mutational hot spot in the p53 gene in human hepatocellular carcinomasNature, 1991
- Medical uses of mylabris in ancient China and recent studiesJournal of Ethnopharmacology, 1989
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989